Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 423

Related Citations for PubMed (Select 22581028)

1.

Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.

Lian ZQ, Wang Q, Li WP, Zhang AQ, Wu L.

Int J Oncol. 2012 Aug;41(2):629-38. doi: 10.3892/ijo.2012.1464. Epub 2012 May 8.

PMID:
22581028
2.

Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays.

Li H, Du Y, Zhang D, Wang LN, Yang C, Liu B, Wang WJ, Shi L, Hong WG, Zhang L, Yang YX.

Oncol Rep. 2012 Jul;28(1):99-104. doi: 10.3892/or.2012.1779. Epub 2012 Apr 23.

PMID:
22552777
3.
4.

Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.

Kim MS, Lee J, Oh T, Moon Y, Chang E, Seo KS, Hoehn BD, An S, Lee JH.

Oncol Rep. 2012 May;27(5):1681-8. doi: 10.3892/or.2012.1691. Epub 2012 Feb 17.

PMID:
22366991
5.

Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.

Tommasi S, Karm DL, Wu X, Yen Y, Pfeifer GP.

Breast Cancer Res. 2009;11(1):R14. doi: 10.1186/bcr2233. Epub 2009 Feb 27.

6.

Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.

Moelans CB, Verschuur-Maes AH, van Diest PJ.

J Pathol. 2011 Oct;225(2):222-31. doi: 10.1002/path.2930. Epub 2011 Jun 27. Erratum in: J Pathol. 2012 Jan;226(1):143.

PMID:
21710692
7.

Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer.

Versmold B, Felsberg J, Mikeska T, Ehrentraut D, Köhler J, Hampl JA, Röhn G, Niederacher D, Betz B, Hellmich M, Pietsch T, Schmutzler RK, Waha A.

Int J Cancer. 2007 Aug 1;121(3):547-54.

PMID:
17415710
8.

Promoter CpG island hypermethylation during breast cancer progression.

Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH.

Virchows Arch. 2011 Jan;458(1):73-84. doi: 10.1007/s00428-010-1013-6. Epub 2010 Dec 1.

PMID:
21120523
9.

Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.

Wu JH, Liang XA, Wu YM, Li FS, Dai YM.

Oncol Rep. 2013 Jan;29(1):125-32. doi: 10.3892/or.2012.2077. Epub 2012 Oct 9.

PMID:
23064448
10.

DNA methylation biomarkers for lung cancer.

Rauch TA, Wang Z, Wu X, Kernstine KH, Riggs AD, Pfeifer GP.

Tumour Biol. 2012 Apr;33(2):287-96. doi: 10.1007/s13277-011-0282-2. Epub 2011 Dec 6.

PMID:
22143938
12.

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.

Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD.

PLoS Med. 2006 Dec;3(12):e486.

13.

Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.

Hellwinkel OJ, Kedia M, Isbarn H, Budäus L, Friedrich MG.

BJU Int. 2008 Mar;101(6):753-7. Epub 2007 Dec 7.

PMID:
18070176
14.

Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.

Yan PS, Shi H, Rahmatpanah F, Hsiau TH, Hsiau AH, Leu YW, Liu JC, Huang TH.

Cancer Res. 2003 Oct 1;63(19):6178-86.

15.

Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.

Faryna M, Konermann C, Aulmann S, Bermejo JL, Brugger M, Diederichs S, Rom J, Weichenhan D, Claus R, Rehli M, Schirmacher P, Sinn HP, Plass C, Gerhauser C.

FASEB J. 2012 Dec;26(12):4937-50. doi: 10.1096/fj.12-209502. Epub 2012 Aug 28.

16.

Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.

Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, Shi DR, Wang P, Yang ZH, Zhu JD.

World J Gastroenterol. 2004 Dec 1;10(23):3441-54.

17.

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D.

Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213.

18.

Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters.

Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP.

PLoS Genet. 2007 Oct;3(10):2023-36. Epub 2007 Sep 10.

19.

Identification of novel DNA methylation markers in cervical cancer.

Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, Chang CC, Yu MH.

Int J Cancer. 2008 Jul 1;123(1):161-7. doi: 10.1002/ijc.23519.

PMID:
18398837
20.

Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.

Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB, Issa JP.

Cancer Res. 1999 May 15;59(10):2307-12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk